(continued)
- FDA Approves Omvoh for Crohn’s Disease
- FDA Approves Zepbound for Obstructive Sleep Apnea
- FDA Approves New Drug for Advanced Lung Cancer
- FDA Approves Nemluvio for Atopic Dermatitis
- FDA Approves Drug for Rare Adrenal Gland Disorder
- FDA Approves New Drug for Advanced Skin Cancer
- FDA Approves Drug for Aggressive Small-Cell Lung Cancer
- FDA Approves New Drug for Lung and Pancreatic Cancers
- FDA Approves New SVT Drug for Critical Care Use
- FDA Approves New Drug for Life-Threatening Heart Condition
- FDA Approves Bimzelx for Hidradenitis Suppurativa
- First-in-Class Leukemia Treatment Approved by FDA
- First Brain-Injected Gene Therapy Approved by FDA
- FDA Approves New Immunotherapy for Aggressive Leukemia
- New Rosacea Treatment Option Approved by the FDA
- FDA Fast-Tracks Asciminib for New Chronic Leukemia Patients
- FDA OKs New Drug for Urinary Tract Infections
- New First-in-Class Drug Approved for Advanced Stomach Cancer
- FDA Approves New Treatment for Advanced Parkinson’s Disease
- Dupixent Gets FDA Approval for COPD
- FDA Approves First Injectable for Relapsing and Progressive MS
- FDA Approves Revolutionary Schizophrenia Drug
- FDA OKs Second Treatment for Rare, Deadly Genetic Disorder
- FDA Approves First At-Home Nasal Flu Vaccine
- FDA Approves First Injectable Version of Cancer Drug